CareDx (CDNA) Tops Q3 EPS by 6c

CareDx (NASDAQ: CDNA) reported Q3 EPS of $0.07, $0.06 better than the analyst estimate of $0.01. Revenue for the quarter came in at $75.6 million versus the consensus estimate of $74.05 million.

GUIDANCE:

CareDx sees FY2021 revenue of $290-293 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance
• JPMorgan Upgrades Sika AG (SIKA:SW) (SKFOF) to Neutral